EP1067925A4 - Antidiabetic agents - Google Patents

Antidiabetic agents

Info

Publication number
EP1067925A4
EP1067925A4 EP99915076A EP99915076A EP1067925A4 EP 1067925 A4 EP1067925 A4 EP 1067925A4 EP 99915076 A EP99915076 A EP 99915076A EP 99915076 A EP99915076 A EP 99915076A EP 1067925 A4 EP1067925 A4 EP 1067925A4
Authority
EP
European Patent Office
Prior art keywords
antidiabetic agents
antidiabetic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99915076A
Other languages
German (de)
French (fr)
Other versions
EP1067925A1 (en
Inventor
Kun Liu
Anthony B Jones
Harold B Wood
Bei Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812208.8A external-priority patent/GB9812208D0/en
Priority claimed from GBGB9823088.1A external-priority patent/GB9823088D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1067925A1 publication Critical patent/EP1067925A1/en
Publication of EP1067925A4 publication Critical patent/EP1067925A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99915076A 1998-04-02 1999-03-29 Antidiabetic agents Withdrawn EP1067925A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US8039898P 1998-04-02 1998-04-02
US80398P 1998-04-02
GB9812208 1998-06-05
GBGB9812208.8A GB9812208D0 (en) 1998-06-05 1998-06-05 Antidiabetic agents
US9613598P 1998-08-10 1998-08-10
GBGB9823088.1A GB9823088D0 (en) 1998-10-21 1998-10-21 Antidiabetic agents
GB9823088 1998-10-21
PCT/US1999/006767 WO1999051225A1 (en) 1998-04-02 1999-03-29 Antidiabetic agents
US96135P 2008-09-11

Publications (2)

Publication Number Publication Date
EP1067925A1 EP1067925A1 (en) 2001-01-17
EP1067925A4 true EP1067925A4 (en) 2003-04-16

Family

ID=27451793

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99915076A Withdrawn EP1067925A4 (en) 1998-04-02 1999-03-29 Antidiabetic agents

Country Status (5)

Country Link
EP (1) EP1067925A4 (en)
JP (1) JP2002510623A (en)
AU (1) AU748432B2 (en)
CA (1) CA2328607A1 (en)
WO (1) WO1999051225A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376529B1 (en) 1995-06-07 2002-04-23 Peng Cho Tang Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof
US5786488A (en) 1996-11-13 1998-07-28 Sugen, Inc. Synthetic methods for the preparation of indolyquinones
US6528037B2 (en) 2000-10-11 2003-03-04 Telik, Inc. Method for determining whether a compound is an insulin receptor kinase activator
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc Method of treating men with metabolic and anthropometric disorders
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
EA201592263A1 (en) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. ULTRASCULAR AGONISTS OF GUANYLACYCLASE C, METHOD OF THEIR RECEIVING AND USING
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
JP6858751B2 (en) 2015-08-20 2021-04-14 アセコー インコーポレイテッド Diabetes Management Therapy Advisor
JP2022508648A (en) 2018-10-05 2022-01-19 アンナプルナ バイオ インコーポレイテッド Compounds and compositions for treating conditions associated with APJ receptor activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020874A1 (en) * 1996-11-13 1998-05-22 Sugen, Inc. Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020874A1 (en) * 1996-11-13 1998-05-22 Sugen, Inc. Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9951225A1 *
ZHANG B ET AL: "Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 284, 7 May 1999 (1999-05-07), pages 974 - 977, XP002145727, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
JP2002510623A (en) 2002-04-09
EP1067925A1 (en) 2001-01-17
AU748432B2 (en) 2002-06-06
CA2328607A1 (en) 1999-10-14
AU3368099A (en) 1999-10-25
WO1999051225A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
GB9928330D0 (en) Novel antidiabetic agents
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
CZ20011594A3 (en) Herbicidal agents
DE59903023D1 (en) Perorale wirkstoff-suspension
EP1067925A4 (en) Antidiabetic agents
DE59904407D1 (en) Chromanderivate
DE59900495D1 (en) Multimetalloxidmassen
TW394296U (en) Markierungselement
DE59900471D1 (en) Inchbremseinrichtung
GB9901709D0 (en) Photobioreacter
GB9922028D0 (en) Steady-step
DE59905941D1 (en) Methoximinophenylessigsäureamide
GB9812208D0 (en) Antidiabetic agents
GB9823088D0 (en) Antidiabetic agents
DE59911094D1 (en) Tryptase-inhibitoren
GB9808628D0 (en) Rotashelf
GB9705857D0 (en) Antidiabetic agents
GB9714319D0 (en) Indolylquinones as antidiabetic agents
PL324932A1 (en) Mould-killing agent
IL136525A0 (en) Agents
ZA97824B (en) Antidiabetic agents
GB9604233D0 (en) Antidiabetic agents
GB9604234D0 (en) Antidiabetic agents
GB9604231D0 (en) Antidiabetic agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001102

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20001102;LT PAYMENT 20001102;LV PAYMENT 20001102;MK PAYMENT 20001102;RO PAYMENT 20001102;SI PAYMENT 20001102

A4 Supplementary search report drawn up and despatched

Effective date: 20030304

17Q First examination report despatched

Effective date: 20030709

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031120